Role of Lateral Pelvic Node Dissection in Rectal Cancer Surgery

Abstract

The role of lateral pelvic lymph node dissection in the treatment of patients with locally advanced rectal cancer is a matter of controversy. Surgical practices in Korea and Japan have accepted this approach and are widely utilized; however, it is not routinely incorporated in the practice of countries in the Western hemisphere. This review will examine the role of lateral pelvic lymph node dissection.

Keywords

locally advanced rectal cancer - lateral pelvic lymph node - lymph node dissection - chemoradiotherapy

Publication History

Article published online:
11 August 2023

• References

• 1 Kim TH, Jeong SY, Choi DH. et al. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection. Ann Surg Oncol 2008; 15 (03) 729-737
• 2 Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg 1982; 144 (03) 350-354
• 3 Moriya Y, Sugihara K, Akasu T, Fujita S. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer 1995; 31A (7-8): 1229-1232
• 4 Moriya Y, Sugihara K, Akasu T, Fujita S. Patterns of recurrence after nerve-sparing surgery for rectal adenocarcinoma with special reference to loco-regional recurrence. Dis Colon Rectum 1995; 38 (11) 1162-1168
• 5 Kapiteijn E, Marijnen CA, Nagtegaal ID. et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345 (09) 638-646
• 6 Cedermark B, Dahlberg M, Glimelius B, Påhlman L, Rutqvist LE, Wilking N. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997; 336 (14) 980-987
• 7 Yano H, Moran BJ. The incidence of lateral pelvic side-wall nodal involvement in low rectal cancer may be similar in Japan and the West. Br J Surg 2008; 95 (01) 33-49
• 8 Georgiou P, Tan E, Gouvas N. et al. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol 2009; 10 (11) 1053-1062
• 9 Wang X, Qiu A, Liu X, Shi Y. Total mesorectal excision plus lateral lymph node dissection vs TME on rectal cancer patients: a meta-analysis. Int J Colorectal Dis 2020; 35 (06) 997-1006
• 10 Anania G, Davies RJ, Arezzo A. et al. Rise and fall of total mesorectal excision with lateral pelvic lymphadenectomy for rectal cancer: an updated systematic review and meta-analysis of 11,366 patients. Int J Colorectal Dis 2021; 36 (11) 2321-2333
• 11 Hajibandeh S, Hajibandeh S, Matthews J, Palmer L, Maw A. Meta-analysis of survival and functional outcomes after total mesorectal excision with or without lateral pelvic lymph node dissection in rectal cancer surgery. Surgery 2020; 168 (03) 486-496
• 12 Ma P, Yuan Y, Yan P. et al. The efficacy and safety of lateral lymph node dissection for patients with rectal cancer: a systematic review and meta-analysis. Asian J Surg 2020; 43 (09) 891-901
• 13 Shihab OC, Taylor F, Bees N. et al; MERCURY Study Group. Relevance of magnetic resonance imaging-detected pelvic sidewall lymph node involvement in rectal cancer. Br J Surg 2011; 98 (12) 1798-1804
• 14 Glass RE, Ritchie JK, Thompson HR, Mann CV. The results of surgical treatment of cancer of the rectum by radical resection and extended abdomino-iliac lymphadenectomy. Br J Surg 1985; 72 (08) 599-601
• 15 Ueno M, Oya M, Azekura K, Yamaguchi T, Muto T. Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer. Br J Surg 2005; 92 (06) 756-763
• 16 Shimoyama M, Yamazaki T, Suda T, Hatakeyama K. Prognostic significance of lateral lymph node micrometastases in lower rectal cancer: an immunohistochemical study with CAM5.2. Dis Colon Rectum 2003; 46 (03) 333-339
• 17 Yang X, Hu T, Gu C. et al. The prognostic significance of isolated tumor cells detected within lateral lymph nodes in rectal cancer patients after laparoscopic lateral lymph node dissection. J Laparoendosc Adv Surg Tech A 2019; 29 (11) 1462-1468
• 18 Hojo D, Murono K, Nozawa H. et al. Utility of a three-dimensional printed pelvic model for lateral pelvic lymph node dissection education: a randomized controlled trial. J Am Coll Surg 2019; 229 (06) 552-559.e3
• 19 Kim HJ, Choi GS, Park JS. et al. S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection. Surg Endosc 2020; 34 (01) 469-476
• 20 Watanabe J, Ishibe A, Suwa Y. et al. Autonomic nerve-preserving lymph node dissection for lateral pelvic lymph node metastasis of the pelvic floor using the transanal approach. Dis Colon Rectum 2020; 63 (01) 113-114
• 21 Senba Y. An anatomical study of the lymphatic system of the rectum. J Fukuoka Med Coll. 1927; 20: 1213-1268
• 22 Kuru M. Cancer of the rectum. J Jpn Surg Soc. 1940; 41: 832-877
• 23 Koyama Y. Extended surgery for rectal cancer (Japanese). Geka Chiryo 1977; 36: 41-45
• 24 Hojo K, Koyama Y. Postoperative follow-up studies on cancer of the colon and rectum. Am J Surg 1982; 143 (03) 293-3
• 25 Sugihara K, Kobayashi H, Kato T. et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum 2006; 49 (11) 1663-1672
• 26 Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K. Japanese Society for Cancer of the Colon and Rectum. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease?. Ann Surg 2012; 255 (06) 1129-1134
• 27 Akiyoshi T, Ueno M, Matsueda K. et al. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging. Ann Surg Oncol 2014; 21 (01) 189-196
• 28 Fujita S, Mizusawa J, Kanemitsu Y. et al; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg 2017; 266 (02) 201-207
• 29 Hashiguchi Y, Muro K, Saito Y. et al; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 2020; 25 (01) 1-42
• 30 Ishihara S, Kawai K, Tanaka T. et al. Oncological outcomes of lateral pelvic lymph node metastasis in rectal cancer treated with preoperative chemoradiotherapy. Dis Colon Rectum 2017; 60 (05) 469-476
• 31 Kim MJ, Chan Park S, Kim TH. et al. Is lateral pelvic node dissection necessary after preoperative chemoradiotherapy for rectal cancer patients with initially suspected lateral pelvic node?. Surgery 2016; 160 (02) 366-376
• 32 Waugh JM, Kirklin JW. The importance of the level of the lesion in the prognosis and treatment of carcinoma of the rectum and low sigmoid colon. Ann Surg 1949; 129 (01) 22-33
• 33 Stearns Jr MW, Deddish MR. Five-year results of abdominopelvic lymph node dissection for carcinoma of the rectum. Dis Colon Rectum 1959; 2 (02) 169-172
• 34 Sauer I, Bacon HE. Influence of lateral spread of cancer of the rectum on radicability of operation and prognosis. Am J Surg 1951; 81 (01) 111-120
• 35 Michelassi F, Block GE. Morbidity and mortality of wide pelvic lymphadenectomy for rectal adenocarcinoma. Dis Colon Rectum 1992; 35 (12) 1143-1147
• 36 Kusters M, Uehara K, Velde CJHV, Moriya Y. Is there any reason to still consider lateral lymph node dissection in rectal cancer? Rationale and technique. Clin Colon Rectal Surg 2017; 30 (05) 346-356
• 37 Sapci I, Delaney CP, Liska D. et al. Oncological outcomes of patients with locally advanced rectal cancer and lateral pelvic lymph node involvement. J Gastrointest Surg 2019; 23 (07) 1454-1460
• 38 Kusters M, Slater A, Muirhead R. et al. What to do with lateral nodal disease in low locally advanced rectal cancer? A call for further reflection and research. Dis Colon Rectum 2017; 60 (06) 577-585
• 39 Kim DJ, Chung JJ, Yu JS, Cho ES, Kim JH. Evaluation of lateral pelvic nodes in patients with advanced rectal cancer. AJR Am J Roentgenol 2014; 202 (06) 1245-1255
• 40 Malakorn S, Yang Y, Bednarski BK. et al. Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation?. Dis Colon Rectum 2019; 62 (10) 1158-1166
• 41 Peeters KCMJ, Marijnen CAM, Nagtegaal ID. et al; Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246 (05) 693-701
• 42 Kusters M, Beets GL, van de Velde CJH. et al. A comparison between the treatment of low rectal cancer in Japan and the Netherlands, focusing on the patterns of local recurrence. Ann Surg 2009; 249 (02) 229-235
• 43 Watanabe T, Tsurita G, Muto T. et al. Extended lymphadenectomy and preoperative radiotherapy for lower rectal cancers. Surgery 2002; 132 (01) 27-33
• 44 Kim JC, Takahashi K, Yu CS. et al. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Ann Surg 2007; 246 (05) 754-762
• 45 Akiyoshi T, Toda S, Tominaga T. et al. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer. BJS Open 2019; 3 (06) 822-829
• 46 Ogura A, Konishi T, Cunningham C. et al; Lateral Node Study Consortium. Neoadjuvant (chemo)radiotherapy with total mesorectal excision only is not sufficient to prevent lateral local recurrence in enlarged nodes: results of the multicenter lateral node study of patients with low cT3/4 rectal cancer. J Clin Oncol 2019; 37 (01) 33-43
• 47 Atef Y, Koedam TW, van Oostendorp SE, Bonjer HJ, Wijsmuller AR, Tuynman JB. Lateral pelvic lymph node metastases in rectal cancer: a systematic review. World J Surg 2019; 43 (12) 3198-3206
• 48 Ahmadi N, Brown KGM, Lee P, Quinn M, Austin KKS, Solomon MJ. Is neoadjuvant chemoradiotherapy sufficient in patients with advanced rectal malignancy and positive extra-mesorectal lateral lymph nodes?. Colorectal Dis 2020; 22 (06) 689-693
• 49 Fujita S, Akasu T, Mizusawa J. et al; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial. Lancet Oncol 2012; 13 (06) 616-621
• 50 Hida K, Nishizaki D, Sumii A. et al; Japan Society of Laparoscopic Colorectal Surgery. Prognostic impact of lateral pelvic node dissection on the survival of patients in low rectal cancer subgroups based on lymph node size. Ann Surg Oncol 2021; 28 (11) 6179-6188
• 51 Tsukamoto S, Fujita S, Ota M. et al; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212). Br J Surg 2020; 107 (05) 586-594